Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

SULFASALAZINE Delayed Release Tablets (GREENSTONE LLC)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

SULFASALAZINE Delayed Release Tablets (GREENSTONE LLC) Quick Finder

INDICATIONS AND USAGE

Sulfasalazine delayed release tablets are indicated:

a)
in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis;
b)...
Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

The dosage of sulfasalazine delayed release tablets should be adjusted to each individual's response and tolerance.

Patients should be instructed to take sulfasalazine delayed release tablets...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Sulfasalazine delayed release tablets are contraindicated in:
Hypersensitivity to sulfasalazine, its metabolites, sulfonamides or salicylates,
Patients with intestinal or urinary obstruction,
...

Did you find an answer to your question? Yes No

WARNINGS

Hepatic, Renal, and Hematologic Toxicity or Other Conditions

Only after critical appraisal should sulfasalazine delayed release tablets be given to patients...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The most common adverse reactions associated with sulfasalazine in ulcerative colitis are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about...

Did you find an answer to your question? Yes No

DRUG ABUSE AND DEPENDENCE

None reported.

Did you find an answer to your question? Yes No

OVERDOSAGE

There is evidence that the incidence and severity of toxicity following overdosage is directly related to the total serum sulfapyridine concentration. Symptoms of overdosage may include nausea, vomiting, gastric...

Did you find an answer to your question? Yes No

DESCRIPTION

Sulfasalazine delayed release tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.

Sulfasalazine delayed release tablets are film coated...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Pharmacodynamics

The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), may be...

Did you find an answer to your question? Yes No

REFERENCES

  1. Van Rossum MAJ, et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Arth Rheum 1998; 41:808–816.
  2. Mogadam M, et al. Pregnancy in...
Did you find an answer to your question? Yes No

HOW SUPPLIED

Sulfasalazine delayed release tablets, 500 mg, are elliptical, gold-colored, film enteric-coated tablets, monogrammed "104" on one side. They are available in the following package sizes:

...
Did you find an answer to your question? Yes No

Enteric-coated Tablets

This product's label may have been updated. For...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event